Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C., Chen W., Luo J., Batty P., Chen Y-L., Nahler J., Wu Y., Pavord ID., Erpenbeck VJ., Sandham DA., Xue L., Ogg G.

DOI

10.1016/j.jaci.2019.02.015

Type

Journal article

Publication Date

2019-06-01T00:00:00+00:00

Volume

143

Pages

2329 - 2333

Total pages

4

Keywords

Cell Aggregation, Cytokines, Humans, Immunity, Innate, Indoleacetic Acids, Lymphocytes, Pyridines, Receptors, Immunologic, Receptors, Prostaglandin

Permalink More information Close